What weight should I use for enoxaparin?
Once daily dosing regimens of enoxaparin are not recommended. BMI 30 to 39 kg/m2: Use standard prophylaxis dosing (ie, 30 mg every 12 hours or 40 mg once daily). BMI ≥40 kg/m2: Empirically increase standard prophylaxis dose by 30% (ie, to 40 mg every 12 hours).
Is Lovenox weight based dosing?
We found that a specific weight-based dose of enoxaparin (0.5 mg/kg subcutaneously once daily without capping the dose) is feasible and results in peak anti-Xa levels within or near recommended range for thromboprophylaxis, without any evidence of excessive anti-Xa activity.
What is the standard dosing for enoxaparin VTE chemoprophylaxis in trauma patients with normal BMI?
Among patients with a BMI less than 40 kg/m2 and CrCl greater than 30 mL/min, pharmacists may adjust the enoxaparin dose to 30 mg SC twice daily in trauma patients and 40 mg SC daily in all other patients.
When do you withhold enoxaparin?
3 • If platelet count is < 50×109/L, enoxaparin is contraindicated3 • If there is a decrease of 30-50% from baseline during treatment, enoxaparin should be discontinued immediately and HIT considered.
Is enoxaparin a low molecular weight heparin?
Enoxaparin belongs to a class of drugs known as “low molecular weight heparin” (LMWH), which is different than heparin, another drug that helps to prevent blood clots. 2.
When should I take weight-based Lovenox?
In morbidly obese, medically-ill patients, use of weight-based enoxaparin dosed at 0.5 mg/kg once daily is feasible and results in peak anti-Xa levels within or near recommended range for thromboprophylaxis, without any evidence of excessive anti-Xa activity.
Is Lovenox a LMWH?
The currently available brands of LMWH approved by FDA in the United States are: Lovenox generic name, enoxaparin manufactured by Sanofi-Aventis. Fragmin generic name, dalteparin manufactured by Pfizer.
When do you give low molecular weight heparin?
Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the prevention of blood clots and treatment of venous thromboembolism (deep vein thrombosis and pulmonary embolism) and in the treatment of myocardial infarction.
What is the recommended DVT prophylaxis for a trauma patient without renal failure?
As noted, 40 mg of enoxaparin twice daily is the recommended initial pharmacologic prophylaxis for most trauma patients.
Is enoxaparin a VTE prophylaxis?
Enoxaparin, used as prophylaxis in medically ill patients at increased risk for thromboembolism, has shown significantly increased efficacy compared with placebo in reducing the incidence of deep vein thrombosis and pulmonary embolism.
Does enoxaparin cause thrombocytopenia?
Enoxaparin-induced thrombocytopenia is rarely encountered, in contrast to its high prevalence among patients treated with unfractionated heparin.
Do you hold Lovenox for low platelets?
Thrombocytopenia can occur with the administration of Lovenox Injection. Thrombocytopenia of any degree should be monitored closely. If the platelet count falls below 100,000/mm3, Lovenox Injection should be discontinued.
Who needs DVT prophylaxis guidelines?
The subject of deep vein thrombosis (DVT) prophylaxis is usually associated with postoperative immobilization or prolonged immobilization in the management of injuries such as fractures or tendon ruptures. The necessity for DVT prophylaxis, particularly in the podiatry patient, remains unclear.
How to calculate Lovenox dose by weight?
Adult Dosage. The recommended dose of Lovenox is a single intravenous bolus of 30 mg plus a 1 mg/kg subcutaneous dose followed by 1 mg/kg administered subcutaneously every 12 hours (maximum 100 mg for the first two doses only, followed by 1 mg/kg dosing for the remaining doses) in patients with acute ST-segment elevation myocardial infarction.
Can you give Lovenox with low platelets?
You should not use Lovenox if you have active bleeding, or a low level of platelets in your blood after testing positive for a certain antibody while using enoxaparin.
What is therapeutic Lovenox dose?
The recommended dose of Lovenox is 1 mg/kg administered subcutaneously every 12 hours in conjunction with oral aspirin therapy (100 to 325 mg once daily) in patients with unstable angina or non–Q-wave myocardial infarction. Treat with Lovenox for a minimum of 2 days and continue until clinical stabilization.